Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Harvey

Showing results (321-330 of 419) with videos related to

Pageof 42
Sort By:
Cell Reports|July 30, 2025
The histone core domain evolves at single-residue resolution to directly orchestrate transcriptionZachary H Harvey, Kathryn M Stevens, Jian Yi Kok, et al.
Breast Cancer Research and Treatment|January 1, 1995
Aromatase inhibitor development for treatment of breast cancerS Masamura, H Adlercreutz, H Harvey, et al.
Obesity Surgery|January 5, 2002
Reduction in psychopathology following bariatric surgery for morbid obesityS R Maddi, S R Fox, D M Khoshaba, et al.
Research in Veterinary Science|February 2, 2021
Hippocampal monoamine changes in the Flinders sensitive line rat: A case for the possible use of selective α<sub>2C</sub>-AR-antagonists in stress and anxiety disorders in companion animalsBrian H Harvey, Madeleine M Uys, Francois P Viljoen, et al.
Journal of Glaucoma|January 9, 2024
Biomechanical and Vascular Metrics Between Eyes of Patients With Asymmetric Glaucoma and Symmetric GlaucomaDevon H Harvey, Cynthia J Roberts, Ashraf M Mahmoud, et al.
Neurotoxicity Research|October 9, 2010
The styrene metabolite, phenylglyoxylic acid, induces striatal-motor toxicity in the rat: influence of dose escalation/reduction over timeGisella Terre'Blanche, Nicolette Heyer, Jacobus J Bergh, et al.
Open Access Journal of Clinical Trials|October 5, 2010
Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancerJill P Smith, Sandra I Bingaman, David T Mauger, et al.
Journal of Addictive Diseases|May 8, 2023
The integration of harm reduction services in the Veterans Health Administration (VHA): a qualitative analysis of barriers and facilitatorsLeah H Harvey, Samantha K Sliwinski, Kimberlee Flike, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Safety and efficacy of bisphosphonates beyond 24 months in cancer patientsS M Ali, F J Esteva, G Hortobagyi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 9, 2021
The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatmentEsmé Jansen van Vuren, Stephan F Steyn, Christiaan B Brink, et al.
Pageof 42

Showing results (321-330 of 419) with videos related to

Sort By:
Pageof 42
Cell Reports|July 30, 2025
The histone core domain evolves at single-residue resolution to directly orchestrate transcriptionZachary H Harvey, Kathryn M Stevens, Jian Yi Kok, et al.
Breast Cancer Research and Treatment|January 1, 1995
Aromatase inhibitor development for treatment of breast cancerS Masamura, H Adlercreutz, H Harvey, et al.
Obesity Surgery|January 5, 2002
Reduction in psychopathology following bariatric surgery for morbid obesityS R Maddi, S R Fox, D M Khoshaba, et al.
Research in Veterinary Science|February 2, 2021
Hippocampal monoamine changes in the Flinders sensitive line rat: A case for the possible use of selective α<sub>2C</sub>-AR-antagonists in stress and anxiety disorders in companion animalsBrian H Harvey, Madeleine M Uys, Francois P Viljoen, et al.
Journal of Glaucoma|January 9, 2024
Biomechanical and Vascular Metrics Between Eyes of Patients With Asymmetric Glaucoma and Symmetric GlaucomaDevon H Harvey, Cynthia J Roberts, Ashraf M Mahmoud, et al.
Neurotoxicity Research|October 9, 2010
The styrene metabolite, phenylglyoxylic acid, induces striatal-motor toxicity in the rat: influence of dose escalation/reduction over timeGisella Terre'Blanche, Nicolette Heyer, Jacobus J Bergh, et al.
Open Access Journal of Clinical Trials|October 5, 2010
Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancerJill P Smith, Sandra I Bingaman, David T Mauger, et al.
Journal of Addictive Diseases|May 8, 2023
The integration of harm reduction services in the Veterans Health Administration (VHA): a qualitative analysis of barriers and facilitatorsLeah H Harvey, Samantha K Sliwinski, Kimberlee Flike, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Safety and efficacy of bisphosphonates beyond 24 months in cancer patientsS M Ali, F J Esteva, G Hortobagyi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 9, 2021
The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatmentEsmé Jansen van Vuren, Stephan F Steyn, Christiaan B Brink, et al.
Pageof 42